Led · Equity · Sep 2025

Genoskin is a French-American contract research organization that leverages donated human skin and proprietary preservation technology to keep immunocompetent skin viable for up to seven days after surgery. The resulting ex vivo platforms generate rich multiomics datasets that are interpreted with AI and advanced bioinformatics to provide human-relevant insights into toxicity and efficacy. Supported by a strong IP portfolio, a reliable tissue-sourcing network and a scalable service model, the company already counts many major global pharmaceutical firms among its clients across biopharma, cosmetics, and cell- and gene-therapy sectors. Genoskin’s technology is particularly valuable for skin-related delivery routes such as injectables, including vaccines, and topically administered drugs. With its first $8.7 million funding round now closed, the company intends to double its workforce within three years and broaden its commercial footprint in Europe and Asia by 2026. Future plans include launching new immune-centric service offerings by 2027, developing biosimulation platforms and novel human immune models, and scaling production through industrial automation. Genoskin will expand manufacturing capacity at upgraded facilities in Salem, Massachusetts in 2026 and Toulouse, France in 2027, enabling doubled skin-model output and U.S. next-day delivery of fresh human mast cells.

Participated · Equity · Dec 2023

Elements is an independent renewable-energy developer founded in 2016 and based in Montpellier that builds and operates greenfield solar, onshore wind and run-of-river hydro projects. The company pursues a participatory, territory-focused model including crowd investment, municipal engagement and consultation of local stakeholders. Elements is developing an integrated offering it calls Smart Renewable Generator (SRG) to combine solar, wind and hydro outputs and provide smoother decarbonized supply. It currently employs about 100 people across offices in Montpellier, Paris, Lyon, Nantes, Bordeaux and Guadeloupe and plans to double headcount by 2030. Elements is accelerating international expansion in markets where it already operates, notably Italy, Finland and Germany. The firm emphasizes employee share ownership and three ESG priorities: reducing CO2 emissions from power production, supporting local acceptability of projects, and promoting staff shareholding.